DIPHERELINE 3,75 mg prašek in vehikel za suspenzijo za injiciranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

diphereline 3,75 mg prašek in vehikel za suspenzijo za injiciranje

ipsen pharma - triptorelin - prašek in vehikel za suspenzijo za injiciranje - triptorelin 3,75 mg / 1 viala - triptorelin

Xevudy Evropska unija - slovenščina - EMA (European Medicines Agency)

xevudy

glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - imunski sera in imunoglobulini, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.

Tolnexa 20 mg/ml koncentrat za raztopino za infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

tolnexa 20 mg/ml koncentrat za raztopino za infundiranje

krka, d.d., novo mesto - docetaksel - koncentrat za raztopino za infundiranje - docetaksel 20 mg / 1 ml - docetaksel

Kapruvia Evropska unija - slovenščina - EMA (European Medicines Agency)

kapruvia

vifor fresenius medical care renal pharma france - difelikefalin - pruritus - vsi drugi terapevtski izdelki - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.

Veklury Evropska unija - slovenščina - EMA (European Medicines Agency)

veklury

gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Rizmoic Evropska unija - slovenščina - EMA (European Medicines Agency)

rizmoic

shionogi b.v. - naldemedine tosilate - zaprtje - zdravila za zaprtje, perifernih opioidni receptor antagonisti - rizmoic je primerna za zdravljenje opioidne povzroča zaprtje (oic) pri odraslih bolnikih, ki so že bili zdravljeni z odvajalo.